Biolife Solutions (BLFS) Cost of Revenue (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cost of Revenue data on file, last reported at $10.0 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 37.91% year-over-year to $10.0 million in Q1 2026; TTM through Mar 2026 was $41.3 million, a 17.99% increase from a year earlier, with the FY2025 full-year figure at $34.1 million, up 38.88% from the prior year.
• Cost of Revenue for Q1 2026 stood at $10.0 million, down from $31.3 million in the prior quarter.
• Over the last five years, Cost of Revenue for BLFS reached as high as $31.3 million in Q4 2025 and fell as low as -$4.5 million in Q4 2022.
• Historically, Cost of Revenue has averaged $6.2 million across 5 years, with a median of $1.9 million in 2022.
• Across the five-year window, Cost of Revenue sank 116.87% in 2022 and surged 438.59% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at -$4.5 million in 2022, then jumped by 438.59% to $15.1 million in 2023, then soared by 44.55% to $21.8 million in 2024, then soared by 43.49% to $31.3 million in 2025, then sank by 68.0% to $10.0 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $10.0 million in Q1 2026, $31.3 million in Q4 2025, and $7000.0 in Q3 2025.